Search Results

There are 35435 results for: content related to: Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma

  1. You have free access to this content
    Rituximab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono and Maria E Suarez-Almazor

    Published Online : 20 JAN 2015, DOI: 10.1002/14651858.CD007356.pub2

  2. Rituximab (Rituxan)

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Pages: 1033–1108, 2008

    Published Online : 1 FEB 2008, DOI: 10.1002/9783527619740.ch39

  3. You have free access to this content
    Publications

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 244–321,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2229

  4. You have free access to this content
    Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma

    British Journal of Haematology

    Volume 150, Issue 2, July 2010, Pages: 200–208, Jorge E. Romaguera, Luis E. Fayad, Lei Feng, Kimberly Hartig, Pamela Weaver, Maria Alma Rodriguez, Fredrick B. Hagemeister, Barbara Pro, Peter McLaughlin, Anas Younes, Felipe Samaniego, Andre Goy, Fernando Cabanillas, Hagop Kantarjian, Larry Kwak and Michael Wang

    Version of Record online : 26 MAY 2010, DOI: 10.1111/j.1365-2141.2010.08228.x

  5. You have free access to this content
    Therapeutic concepts in mantle cell lymphoma

    European Journal of Haematology

    Volume 85, Issue 5, November 2010, Pages: 371–386, Jose Rodriguez, Antonio Gutierrez, Antonia Obrador-Hevia, Silvia Fernandez de Mattos and Fernando Cabanillas

    Version of Record online : 21 OCT 2010, DOI: 10.1111/j.1600-0609.2010.01515.x

  6. You have free access to this content
    Immunotherapy in mantle cell lymphoma: Anti-CD20-based therapy and beyond

    American Journal of Hematology

    Volume 83, Issue 2, February 2008, Pages: 144–149, Yuhong Zhou, Liang Zhang, Jorge Romaguera, Kay Delasalle, Xiaohong Han, Xin Du, Larry Kwak, Qing Yi and Michael Wang

    Version of Record online : 23 AUG 2007, DOI: 10.1002/ajh.21036

  7. You have free access to this content
    Poster Presentations

    Hematological Oncology

    Volume 33, Issue S1, June 2015, Pages: 181–243,

    Version of Record online : 9 JUN 2015, DOI: 10.1002/hon.2228

  8. You have free access to this content
    PUBLICATION

    Hematological Oncology

    Volume 31, Issue S1, June 2013, Pages: 201–270,

    Version of Record online : 17 JUN 2013, DOI: 10.1002/hon.2059

  9. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  10. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  11. Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B-Cell Levels Do Not Correlate With Clinical Response

    The Journal of Clinical Pharmacology

    Volume 47, Issue 9, September 2007, Pages: 1119–1128, Dr Ferdinand Breedveld, Dr Sunil Agarwal, Dr Ming Yin, Dr Song Ren, Dr Nicole F. Li, Dr Tim M. Shaw and Dr Brian E. Davies

    Version of Record online : 23 APR 2013, DOI: 10.1177/0091270007305297

  12. Cochrane Clinical Answers

    In people with rheumatoid arthritis, what are the benefits and harms of two 1000 mg intravenous courses of rituximab?

    Published Online: 31 MAR 2015, DOI: 10.1002/cca.692
  13. You have free access to this content
    British HIV Association guidelines for HIV-associated malignancies 2014

    HIV Medicine

    Volume 15, Issue S2, March 2014, Pages: 1–92, Writing Group, Prof Mark Bower, Dr A Palfreeman, Dr Maryam Alfa-Wali, Prof Chris Bunker, Dr Fiona Burns, Dr Duncan Churchill, Mr Simon Collins, Dr Kate Cwynarski, Dr Simon Edwards, Dr Paul Fields, Dr Kate Fife, Dr Eve Gallop-Evans, Dr Shireen Kassam, Dr Ranjababu Kulasegaram, Prof Charles Lacey, Dr Robert Marcus, Dr Sylvia Montoto, Dr Mark Nelson, Dr Tom Newsom-Davis, Dr Chloe Orkin, Ms Kate Shaw, Dr Melinda Tenant-Flowers, Dr Andrew Webb, Dr Sarah Westwell and Mr Matt Williams

    Version of Record online : 14 FEB 2014, DOI: 10.1111/hiv.12136

  14. You have free access to this content
    Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen

    British Journal of Haematology

    Volume 154, Issue 3, August 2011, Pages: 357–362, Steven P. Treon, Christina Hanzis, Robert J. Manning, Leukothea Ioakimidis, Christopher J. Patterson, Zachary R. Hunter, Patricia Sheehy and Barry Turnbull

    Version of Record online : 25 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08750.x

  15. You have free access to this content
    Follicular lymphoma: 2012 update on diagnosis and management

    American Journal of Hematology

    Volume 87, Issue 10, October 2012, Pages: 988–995, Arnold Freedman*

    Version of Record online : 24 SEP 2012, DOI: 10.1002/ajh.23313

  16. You have free access to this content
    Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi

    British Journal of Haematology

    Volume 156, Issue 3, February 2012, Pages: 346–353, Francesco Merli, Stefano Luminari, Fiorella Ilariucci, Mario Petrini, Carlo Visco, Achille Ambrosetti, Caterina Stelitano, Francesco Caracciolo, Nicola Di Renzo, Francesco Angrilli, Angelo M. Carella, Isabella Capodanno, Elisa Barbolini, Sara Galimberti and Massimo Federico

    Version of Record online : 7 DEC 2011, DOI: 10.1111/j.1365-2141.2011.08958.x

  17. Prognostic model for mantle cell lymphoma in the rituximab era: a nationwide study in Japan

    British Journal of Haematology

    Volume 170, Issue 5, September 2015, Pages: 657–668, Dai Chihara, Naoko Asano, Ken Ohmachi, Tomohiro Kinoshita, Masataka Okamoto, Yoshinobu Maeda, Ishikazu Mizuno, Kosei Matsue, Toshiki Uchida, Hirokazu Nagai, Momoko Nishikori, Shigeo Nakamura, Michinori Ogura and Ritsuro Suzuki

    Version of Record online : 7 MAY 2015, DOI: 10.1111/bjh.13486

  18. Chemotherapy plus Rituximab versus chemotherapy alone for B-cell non-Hodgkin's lymphoma

    Intervention Review

    The Cochrane Library

    Holger Schulz, Julia Bohlius, Nicole Skoetz, Sven Trelle, Thilo Kober, Marcel Reiser, Martin Dreyling, Michael Herold, Guido Schwarzer, Michael Hallek and Andreas Engert

    Published Online : 17 OCT 2007, DOI: 10.1002/14651858.CD003805.pub2

  19. You have free access to this content
    VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study

    British Journal of Haematology

    Volume 155, Issue 2, October 2011, Pages: 190–197, Julie E. Chang, Christopher Peterson, Sangbum Choi, Jens C. Eickhoff, KyungMann Kim, David T. Yang, Leslie A. Gilbert, Eric S. Rogers, Jae E. Werndli, Michael S. Huie, Thomas A. McFarland, Michael Volk, Jules Blank, Natalie S. Callander, Walter L. Longo and Brad S. Kahl

    Version of Record online : 16 AUG 2011, DOI: 10.1111/j.1365-2141.2011.08820.x

  20. You have free access to this content
    A phase 1 dose escalation study of bortezomib combined with rituximab, cyclophosphamide, doxorubicin, modified vincristine, and prednisone for untreated follicular lymphoma and other low-grade B-cell lymphomas

    Cancer

    Volume 118, Issue 14, 15 July 2012, Pages: 3538–3548, Rajni Sinha, Jonathan L. Kaufman, Hanna Jean Khoury Jr., Nassoma King, Pareen J. Shenoy, Carol Lewis, Kevin Bumpers, Amanda Hutchison-Rzepka, Mourad Tighiouart, Leonard T. Heffner, Mary Jo Lechowicz, Sagar Lonial and Christopher R. Flowers

    Version of Record online : 3 JAN 2012, DOI: 10.1002/cncr.26660